CAS 1791420-09-1
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits trouvés.
Dilpacimab
CAS :Dilpacimab (ABT165) is a dual-variable antibody that targets DLL4 and VEGF pathways, showing potential in cancer research by blocking angiogenesis and Notch.Degré de pureté :95% - 97.7% (SDS-PAGE); 95.6% (SEC-HPLC)Couleur et forme :Transparent LiquidMasse moléculaire :199.37 kDaDilpacimab
CAS :A humanized dual-variable domain antibody targets both delta-like ligand 4 (DLL4) and VEGF pathways
